Arkolith/Insider Trading/AVTE/Form 4

Grayzel David S.

DirectorAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Apr 11, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$334K
Net Open-Market Flow
-$334K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2024Sell(S)12K$28.15$334K15K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-010709) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML